View Older Stories View More Recent Stories

Jun 21, 2021 08:00AM CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research
May 27, 2021 08:00AM CytomX Therapeutics to Present at Jefferies Virtual Healthcare Conference
May 6, 2021 04:15PM CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
Apr 29, 2021 08:00AM CytomX Therapeutics to Announce First Quarter 2021 Financial Results on May 6, 2021
Apr 14, 2021 04:01PM CytomX Therapeutics Announces New Employment Inducement Grants
Mar 24, 2021 08:00AM CytomX Therapeutics to Host Virtual Investor Event on April 7, 2021
Feb 24, 2021 04:15PM CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 22, 2021 08:00AM CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences
Feb 19, 2021 08:00AM CytomX Therapeutics Announces New Employment Inducement Grant
Feb 17, 2021 08:00AM CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Feb 4, 2021 08:00AM CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day
Jan 19, 2021 08:00AM CytomX Therapeutics Announces New Employment Inducement Grants
Jan 7, 2021 08:00AM CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 22, 2020 04:05PM CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
Dec 3, 2020 08:00AM CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer Symposium
Nov 11, 2020 04:01PM CytomX Therapeutics to Present at Upcoming Investor Conferences
Nov 5, 2020 04:15PM CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
Nov 5, 2020 08:00AM CytomX Therapeutics Announces Treatment of First Patient in Phase 2 Expansion Study of CX-2029, an Anti-CD71 Probody Drug Conjugate
Oct 29, 2020 08:00AM CytomX Therapeutics to Announce Third Quarter 2020 Financial Results
Oct 6, 2020 04:10PM CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.
Sep 18, 2020 08:00AM CytomX Therapeutics Announces New Employment Inducement Grants
Sep 2, 2020 08:00AM CytomX Therapeutics to Participate in Upcoming Healthcare Conferences
Aug 6, 2020 04:15PM CytomX Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
Aug 4, 2020 08:00AM CytomX Therapeutics to Participate in the 2020 Wedbush PacGrow Healthcare Conference
Jul 28, 2020 08:00AM CytomX Therapeutics to Announce Second Quarter 2020 Financial Results
Jun 22, 2020 09:00AM CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AACR Annual Meeting
May 29, 2020 08:02AM CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program
May 28, 2020 04:05PM CytomX Therapeutics to Participate at Upcoming Healthcare Conferences
May 26, 2020 08:00AM CytomX Therapeutics to Host Conference Call and Webcast to Review ASCO ASCO20 Virtual Scientific Program Presentations
May 13, 2020 05:37PM CytomX Therapeutics (CTMX) Announces Details of Presentations at ASCO
May 13, 2020 05:18PM CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program
May 7, 2020 04:10PM CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
May 5, 2020 08:00AM CytomX Therapeutics to Present at the 2020 Bank of America Securities Health Care Conference
Apr 29, 2020 04:05PM CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific Program
Apr 28, 2020 05:11PM CytomX Therapeutics (CTMX) Names Halley E. Gilbert to Board
Apr 28, 2020 04:05PM CytomX Therapeutics Appoints Halley E. Gilbert to Board of Directors
Apr 27, 2020 08:00AM CytomX Therapeutics to Announce First Quarter 2020 Financial Results
Mar 30, 2020 04:15PM CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on Clinical Stage Pipeline
Mar 25, 2020 04:02PM CytomX Therapeutics Announces New Employment Inducement Grant
Mar 24, 2020 09:14AM Pre-Open Movers 03/24: (GSAT) (NVAX) (CTMX) Higher; (MIST) (BXRX) (HOTH) Lower (more...)
Mar 24, 2020 09:06AM CytomX Therapeutics (CTMX), Astellas Enter Collaboration to Develop Probody T-Cell
Mar 23, 2020 08:00PM CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer
Mar 23, 2020 04:02PM CYTOMX THERAPEUTICS ANNOUNCES APPOINTMENT OF CARLOS CAMPOY AS CHIEF FINANCIAL OFFICER
Mar 16, 2020 04:23PM CytomX Therapeutics Announces New Employment Inducement Grant
Feb 27, 2020 04:28PM CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business Update
Feb 25, 2020 08:00AM CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference
Feb 24, 2020 08:07AM Bristol-Myers Squibb (BMY), CytomX Therapeutics (CTMX) Begin Randomized Ph.2 Cohort Expansion in Ongoing Phase 1/2a Clinical Trial of Anti-CTLA-4 Probody Therapeutic BMS-986249
Feb 24, 2020 08:00AM Bristol-Myers Squibb Advances CytomX Therapeutics’ Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expansion (Part 2a) of Ongoing Clinical Trial
Feb 20, 2020 08:00AM CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results
Jun 14, 2018 07:30AM CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel
View More Recent Stories View Older Stories